The Association of Chronic Pain and Complementary Health Approach Usage: A Comprehensive Analysis Adjusting for Demographics

慢性疼痛与辅助疗法使用之间的关联:一项根据人口统计学因素调整的综合分析

阅读:2

Abstract

BACKGROUND: Chronic pain is a significant public health issue linked to reduced quality of life and higher healthcare costs. Its complex etiology complicates treatment plans, leading many to seek complementary health approaches (CHAs). However, utilization patterns and clinical effects remain understudied. OBJECTIVE: To quantify the association between chronic pain and CHA utilization in US adults, focusing on osteopathic manipulative treatment and other non-traditional modalities, and to evaluate whether associations persist after adjusting for demographics. METHODS: A cross-sectional online survey of 3022 US adults examined CHA use among individuals diagnosed with chronic pain in the past year. Statistical analyses included Chi-Square tests of bivariate associations and logistic regression to evaluate associations with and without demographic adjustments. CHAs were categorized into the five NIH-defined groups: Physical, Psychological, Nutritional, Combined, and System-Based, encompassing nearly 30 interventions. CHA usage, favorable expectation, and favorable experience of these modalities were analyzed. RESULTS: Individuals with chronic pain demonstrated significantly higher overall utilization of CHAs than those without (aOR = 2.36, 95% CI: 1.44-3.87), including osteopathic manipulative treatment (aOR = 3.29, 95% CI: 2.15-5.02). Despite low expectancy for positive outcomes across groups, chronic pain patients reported lower expectations for various modalities. Favorable experience for Any CHA among those with chronic pain was high (93.5%), especially for physical CHAs, acupuncture, and art, music, or dance therapy. CONCLUSION: The increased use of CHAs among chronic pain patients underscores unmet needs in conventional care. Future longitudinal research should further clarify the factors influencing CHA adoption and evaluate their therapeutic efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。